Open AccessFactors Associated with Interest in Initiating Treatment for Hepatitis C Virus (HCV) Infection among Young HCV‐Infected Injection Drug Users
Author(s) -
Steffanie A. Strathdee,
Mary H. Latka,
Jennifer V. Campbell,
P. T. O’Driscoll,
Elizabeth T. Golub,
Farzana Kapadia,
Robin A. Pollini,
Richard S. Garfein,
David L. Thomas,
Holly Hagan
Publication year - 2005
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/427445
Subject(s) - medicine , hepatitis c virus , hepatitis c , cirrhosis , liver disease , substance abuse , immunology , virus , psychiatry
We sought to identify factors associated with interest in receiving therapy for hepatitis C virus (HCV) infection among HCV-infected injection drug users (IDUs) in 3 United States cities.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom